PAR6 COST-UTILITY ANALYSIS OF RITUXIMAB AS A NEW THERAPEUTIC OPTION FOR RHEUMATOID ARTHRITIS PATIENTS IN CANADA
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63265-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)63265-2/fulltext
Section Title :
Section Order :
117
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63265-2&doi=10.1016/S1098-3015(10)63265-2